Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Mycoplasma Testing Market Size Shifted, And What Is the Outlook Through 2034?

The market size for mycoplasma testing has seen considerable growth recently. The forecast suggests an increase from $1.08 billion in 2024 to $1.23 billion in 2025, promising a compound annual growth rate (CAGR) of 13.3%. Factors contributing to its growth during the historic period include outbreak occurrences and contamination incidents, heightened public awareness, progress in the biotechnology sector, research and development efforts, trends in the healthcare industry, and an increase in cell culture production.

The market size for mycoplasma testing is anticipated to witness significant growth in the coming years, expanding to$1.9 billion in 2029 with a compound annual growth rate (CAGR) of 11.6%. This growth during the prediction period is due to increased need for quality assurance, growth in the emerging markets, expansion of the biopharmaceutical industry, surge in cell-based therapies, and growth in the biotech sector. Key trends for the forecasting period include adherence to regulatory standards and compliance, awareness in healthcare and diagnostics, worldwide pandemic readiness, innovation in point-of-care testing, and market penetration in newly emerging economies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Mycoplasma Testing Market?

The growing occurrence of mycoplasma pneumonia is anticipated to boost the mycoplasma testing market. Mycoplasma pneumonia is a respiratory infection caused by Mycoplasma pneumoniae bacteria. Crucial diagnosis of Mycoplasma pneumonia is possible through mycoplasma testing, which identifies the bacteria in respiratory specimens, thereby enabling prompt and accurate recognition of the infection for suitable medical intervention and management. For instance, the Centers for Disease Control and Prevention, a US-based government agency, estimated that in December 2023, around 2 million cases of Mycoplasma pneumoniae infections occur annually in the United States. As a result, the escalating prevalence of mycoplasma pneumonia is fuelling the expansion of the mycoplasma testing market.

Which Key Market Segments Comprise the Mycoplasma Testing Market and Drive Its Revenue Growth?

The mycoplasma testingmarket covered in this report is segmented –

1) By Product: Instruments; Assay, Kits, and Reagents

2) By Technology: PCR; ELISA; Enzymatic Methods; DNA Staining; Other Technologies

3) By Application: Cell line Testing; Virus Testing; End- of- Production Cell Testing

4) By End User: Pharmaceutical & Biotechnology Companies; Cell Banks & Laboratories; Contract Research Organizations; Academic Research Institutes

Subsegments:

1) By Instruments: Mycoplasma Detection Systems; Automated Test Equipment; PCR Equipment

2) By Assay: Mycoplasma Assays (PCR-Based, Culture-Based); Qualitative Assays; Quantitative Assays

3) By Kits: Mycoplasma Detection Kits; Mycoplasma Testing Kits for Cell Cultures; Sample Preparation Kits

4) By Reagents: Nucleic Acid Reagents; Cell Culture Reagents; Staining Reagents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=4103&type=smp

Which Areas Are Leading Regions in the Mycoplasma Testing Market Expansion Across the Globe?

North America was the largest region in the mycoplasma testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the mycoplasma testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theMycoplasma Testing Market Over the Coming Years?

Significant companies in the mycoplasma testing market are pursuing a variety of strategic investments like innovative product launches, advancements in research and development, and technological revolutions, which are receiving significant attention. In a bid to satisfy the demands of end-users and broaden their consumer base, firms are unveiling groundbreaking products in order to remain competitive in the business landscape. For example, SwiftDx, a British biotech firm, introduced a fresh mycoplasma contamination screening test in October 2022, utilizing a PCR-centric approach. The SwiftDx Mycoplasma Detection Kit is a rapid lateral flow test providing a swift and precise method for mycoplasma identification. This test necessitates a minimal sample straight from the cell culture media supernatant without disturbing cell growth. The outcome is portrayed in a clear and easily comprehensible manner. This test exhibits high sensitivity and specificity with a detection limit below 10 cfu/mL post the third day of culture.

View the full report here:

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

How Is the Mycoplasma Testing Market Conceptually Defined?

The mycoplasma testing detects mycoplasma pneumoniae, which causes mycoplasma pneumonia. Mycoplasma pneumonia is a contagious respiratory infection that spreads easily through contact with respiratory fluids. It can cause epidemics. Mycoplasma testing includes a group of tests that measures antibodies in the blood produced in response to a mycoplasma infection and detects the microbe directly through detecting or culturing its genetic material (DNA) in a body sample.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4103

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model